In a research report released today, Wedbush analyst Liana Moussatos maintained an Outperform rating on shares of Omeros Corporation (NASDAQ:OMER) with a price target …
Wedbush analyst Liana Moussatos was out pounding the table on Lexicon Pharmaceuticals, Inc. (NYSE:LXRX) Thursday, reiterating an Outperform rating and price target of $19, which …
In a research report released Friday, Wedbush analyst Liana Moussatos reiterated an Outperform rating on shares of Xoma Corp (NASDAQ:XOMA), while reducing the price …
Wedbush analyst Liana Moussatos weighed in with her views on Intercept Pharmaceuticals Inc (NASDAQ:ICPT), after the company released its second-quarter results, posting $0.445 million in licensing revenue, compared to consensus …
In a research report released today, Wedbush analyst Liana Moussatos reiterated an Outperform rating on Receptos Inc (NASDAQ:RCPT), after the biopharma company released its second-quarter results, …
Xoma Ltd (NASDAQ:XOMA) shares are dropping 76.56% to $1.
Receptos Inc (NASDAQ:RCPT) shares rose 10 per cent in after-hours trading, following the news that Celgene Corporation (NASDAQ:CELG) intends to acquire Receptos for $232/share or $7.2 billion net …
Last week, Liana Moussatos of Wedbush released a report highlighting a list of upcoming catalysts for biopharmaceutical companies. Specifically, she noted forthcoming events …
Wedbush’s healthcare analyst Liana Moussatos weighed in today with a favorable report on Omeros Corporation (NASDAQ:OMER), reiterating an Outperform rating and a $61 price target, which represents a …
Wedbush analyst Liana Moussatos weighed in with her views on Intercept Pharmaceuticals Inc (NASDAQ:ICPT), after the company yesterday announced that it has completed its NDA filing for OCA …
